Your Undivided Attention AI and Cancer: Why Superintelligence Won’t Get Us to a Cure
213 snips
Apr 30, 2026 
Dr. Emilia Javorsky, a physician and public health researcher who directs the Futures Program at the Future of Life Institute, challenges the seductive claim that superintelligent AI will cure cancer. She contrasts narrow AI wins in imaging and drug chemistry with cancer’s biological complexity. She warns about misplaced investments, clinical trial limits, and urges practical fixes: data, incentives, and targeted tools.
AI Snips
Chapters
Books
Transcript
Episode notes
Biology Lacks First Principles Making ASI Less Effective
- Biology lacks simple first principles like physics, making full simulation infeasible even with massive compute.
- Emilia argues emergent complexity prevents ASI-style universal reasoning from easily solving biology.
COVID Speedup Doesn't Generalize To Chronic Diseases
- COVID accelerated vaccine development because outcomes were rapid, trials short, and decades of mRNA research predated the pandemic.
- Emilia says that doesn't generalize to chronic diseases like cancer that need long follow-up.
AlphaFold Was A Data Breakthrough As Much As An AI One
- AlphaFold succeeded because of massive, curated public datasets (Protein Data Bank) as much as model advances.
- Emilia credits decades of shared structural data enabling AI to learn sequence-to-structure relationships.
